Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | AXT Bring Novel Photoacoustic Imaging Technology to Australian Medical ResearchersAXT have recently been appointed distributor for Luxonus' 3D photoacoustic imager. This next-generation medical imaging technology generates more data, in greater detail, with less risk for patients and is ideal for medical research.
By: AXT Pty Ltd Luxonus' photoacoustic 3D imaging (PAI) provides super-high-resolution 3D imaging of blood vessels and lymph vessels safely and easily without using radiation exposure. Born out of Kyoto University and Keio University, and developed under the ImPACT program, a large national project, run by Japan's Cabinet Office to promote high-risk, high-impact R&D, this technology allows the accurate study of the morphology and function of blood vessels and lymphatic vessels. The resultant data enables a comprehensive understanding of the onset of disease, the healing process and the state of health before and after illness. Takayuki Yagi , Exective Director CTO from Luxonus said of the new distribution agreement with AXT, "we are pleased to partner with AXT to bring our technology to Australia as we know they have a strong presence in the preclinical imaging sector and are well positioned to be able to grow our business in their region". In response, Richard Trett, Managing Director at AXT said, "we are excited to embrace another new technology that we know will help Australian researchers maintain their world-leading status in medical research, with the added benefit of opportunities to publish research using a new technology". For more details about the Luxonus 3D Photoacoustic Imager and AXT's other complimentary preclinical image product lines, please visit https://www.axt.com.au/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|